MULTIPLE MYELOMA (MM)

Clinical trials for MULTIPLE MYELOMA (MM) explained in plain language.

Never miss a new study

Get alerted when new MULTIPLE MYELOMA (MM) trials appear

Sign up with your email to follow new studies for MULTIPLE MYELOMA (MM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 11 Not yet recruiting 17 Not yet finished but already full! 1 Completed 2 Terminated 2

New myeloma drug combo aims to replace stem cell transplants

Disease control Terminated

This study was designed to test a new drug called linvoseltamab combined with standard chemotherapy drugs (bortezomib and lenalidomide) in people newly diagnosed with multiple myeloma who are eligible for a stem cell transplant. The goal was to see if this combination, with or wi…

Matched conditions: MULTIPLE MYELOMA (MM)

Phase: PHASE2, PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

MULTIPLE MYELOMA (MM)

Get alerted when new MULTIPLE MYELOMA (MM) trials appear

New myeloma drug combo aims to replace stem cell transplants